Dr. Sean David Adrean

M.D. | Retina Specialist | 26+ years Exp


Medicare Enrolled
 301 W Bastanchury Rd, 285, Fullerton
    California, 92835-3419

 714-738-4620    714-738-0388   Maps & Directions
Dr. Sean David Adrean is a Fullerton, California based Retina Specialist with 26 years of experience in Retina Specialist. He completed his graduation from Loma Linda University School Of Medicine in 2000. He is also affiliated with hospitals like St Jude Medical Center and Los Alamitos Medical Center. He accepts the Medicare-approved amount. Patients will not be billed for any more than the Medicare deductible and coinsurance. Active license number of Dr. Sean David Adrean is A77222 for Retina Specialist in California.
Dr. Sean David Adrean specializes in the diagnosis and treatment of vitreoretinal diseases. This subspecialty includes the medical and surgical management of retinal and vitreous diseases, including retinal detachment, diabetic retinopathy, macular degeneration, and other disorders of the retina and vitreous.
Complete Profile:
Dr. Sean David Adrean speciality, credentials, practice address, contact phone number and fax are as below. Patients can directly walk in or can call on the below given phone number for appointment.
Specialization: Retina Specialist
Credentials: M.D.
Experience: 26+ years
Medical School Attended:Loma Linda University School Of Medicine
Graduation Year:2000
Gender:Male
Accepts Medicare Assignment:Yes
Practice Address:301 W Bastanchury Rd, 285, Fullerton,
California, 92835-3419
Phone:714-738-4620
Fax:714-738-0388
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS). NPI details are as mentioned below.
PAC ID: 1052384260
Enrollment ID: I20060728000179
NPI Number: 1073566568
NPI Enumeration Date: 18 May, 2006
NPI Last Update On: 04 Mar, 2022
Medical Licenses:
Doctors can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Dr. Sean David Adrean are as mentioned below.
License NumberSpecializationStateStatus
A77222Retina Specialist CaliforniaPrimary
Hospital Affiliation:
Doctors can be affiliated to many hospitals whom they worked with in the past or are presently working with. One surgeon can be affiliated to four to five hospitals at a time.
Hospital Name (CCN) State Hospital Type
St Jude Medical Center (050168)Fullerton, CAAcute Care Hospital
Los Alamitos Medical Center (050551)Los alamitos, CAAcute Care Hospital
Group Practice:
Group practices are run by a group of physicians who share their premises and other resources. Following list states all the group name with which Dr. Sean David Adrean has association with along with the number of members in that group.
Organization Name (Group PAC ID) Members
Mohammad Reza Neal Md Inc (0345386017)2
Retina Consultants Of Orange County, A Medical Corporation (8921906017)5
Other Medical Identifiers:
Other legacy medical identifiers associated with Dr. Sean David Adrean such as Medicaid, Medicare PIN, NSC, UPIN etc. are mentioned as below.
IdentifierTypeStateIssuer
A77222OtherCaliforniaMEDICAL LICENSE
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address: 301 W Bastanchury Rd, 285
Fullerton, California
Zip: 92835-3419
Phone Number: 714-738-4620
Fax Number: 714-738-0388
Patients can reach Dr. Sean David Adrean at 301 W Bastanchury Rd, 285, Fullerton, California or can call to book an appointment on 714-738-4620.
Comments/ Reviews:
Patients can read all the reviews posted for Dr. Sean David Adrean below. You may also share your own experience like the quality of treatment, behavior, and overall care provided by Dr. Sean David Adrean. It will help others make informed decisions.
** Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 08 June, 2026.